🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This model highlights many possible applications of AI in healthcare. Importantly, the administrative tasks don’t directly impact patient care, so are not considered medical devices and may have fewer regulatory barriers for implementation. Westyn Branch-Elliman, M.D., MMSc., FSHEA MICHR

A Systematic Review of Safety and Efficacy of #Factor XI/XIa Inhibitors in Patients With ESKD on #Hemodialysis #VisualAbstract by M Abdul Qader🇧🇩 kireports.org/article/S2468-… Cihan Ay Daniel Steiner

I'll be there discussing the latest developments in thrombosis and anticoagulation - I hope you'll join me!

A new RCT from 🇷🇺 showed non-inferiority of non-immunogenic staphylokinase to alteplase in 310 patients with massive PE. jthjournal.org/article/S1538-…

🌟Come Join Our Team🌟 🌟2 New Positions, remote/hyrbid🌟 We are looking for skilled pharmacists to grow our Anticoag Stewardship program. This role will focus on CDTM based outpt mgmt of antithrombotic therapy #AnticoagStewardship #jobs #TwitteRx jobs.bilh.org/job/burlington…

🔍 Discover advanced anticoagulation strategies for thrombotic risk at #AHA24! 📊 Review safety, tackle undertreatment, and gain insights on factor XI inhibitors for AF, stroke, ACS, and VTE with Robert Harrington, Dr Roxana Mehran, and Geoff Barnes. 💥 Dive in: ms.spr.ly/6011WiceR

🔊 Recording is now available for the "Ask the Experts" webinar. Watch here: bit.ly/3QLuunC Thank you to our amazing panelists Drs. Arthur Allen (Arthur Allen), Allison Burnett (@aburnett_PharmD), Geoffrey Barnes (Geoff Barnes), Tara Lech, (Tara Lech PharmD, CACP) Anita

🚨 Exciting news: Our abstract submission portal for #ISTH2025 opens Nov 29! Mark your calendars, and get ready to contribute to what promises to be our most impactful Congress yet. Abstract guidelines are now available at isth2025.org/abstracts

#SUMMIT trial 🫀 Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with HFpEF & obesity. Key slides ⬇️ CardioNerds AHA Science #AHA2024

1) Welcome to #AHA2024 #AHA24 from #Chicago! @cardiomet_ce is HERE for you with breaking news from further analysis of the #AZALEA #TIMI_71 data on #FXI inhibition for #stroke reduction in #AFib. Earn CE/#CME credit from following this 🧵!

💊 GDMT for HFrEF 👇AF incidence and overall burden ⚡️SOLVD trial and Val-HEFT trial: ACEi and ARBs👇incident AF ⚡️EMPHASIS trial: MRA 👇 incident AF ⚡️DAPA-HF: SGLT2 i 👇 incident AF 👉Effects of beta blockers on incident AF less clear

Say NO 🛑 to drugs! (AADs). Results of CASTLE-AF trial highlighting burden of AF between AAD vs ablation:

A Rare Opportunity for Emerging Leaders in CV Education - Apply Now! Don’t miss this exclusive opportunity to apply for the prestigious Rick Nishimura, MD, MACC and Patrick T. O’Gara, MD, MACC Emerging Faculty Leadership Academy, taking place April 27 – 29, 2025. 🔗

We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not a tracked outcome, but hardly any patients were even capable of menstruation. Read our call to action for improving capture of HMB in anticoagulant trials. authors.elsevier.com/a/1k6ci5TuFxIu…

Science! Have you read the #PEERLESS trial comparing #thrombectomy (#LBMT) with #catheter-directed #thrombolysis (#CTD) for Intermediate-risk #pulmonary #embolism (#PE)? A critical read and analysis: 🧵1/5 ahajournals.org/doi/10.1161/CI…

Does this change our standard for how long to treat cancer-associated VTE? It was a select group, but efficacy benefit without more bleeding is compelling

Going live in a few minutes. Join us for this excellent conversation!!!

15 minute AHA Recap for thromboembolic disease! ➡️ ms.spr.ly/6013oXAHP Geoff Barnes reviews ONCO PE Trial, finding if you can tolerate an anticoagulant, then extended courses tend to not increase bleeding over the long term, but have huge benefits in preventing recurrent PE.

🌟 I am so excited to be speaking at the 5th Annual Going Back to the Heart of Cardiology Conference January 24-26 in Miami Beach. Looking forward to sharing and learning alongside the best in the field. See you there! Register here: heartofcardio.com #HeartofCardio